LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

The Quick Take
LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to guidance by pressure wire-based FFR. Conclusive trial results provide further randomized clinical evidence...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Pudu Robotics představuje PUDU TOMO S: Automatizovanou péči o trávník rozšiřuje o broušení žacích nožů
Společnost PUDU přináší své zkušenosti s komerční robotikou do domácností a kombinuje automatickou údržbu žacích nožů, přesné sečení okrajů trávníku a…
Business
Copia Brings Industrial Backup and Recovery to Large, Multi-Vendor Operations With Support for 160+ Integrations
The milestone gives food and beverage manufacturers, materials handling operations, and critical infrastructure providers one platform to back up, track, and…
Business
Antietam Broadband Rewards Customer Loyalty with Automatic Speed Upgrades
Thousands of Washington County customers get a free upgrade and faster internet Logo -…
Business
ADC Therapeutics to Present at November Investor Conferences
LAUSANNE, Switzerland, Nov. 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody…
